Hem CME/CE Courses – Update

Hematology CME/CE Courses

myCME Your search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.

Featured Courses

The Pathologist’s Perspective: The Importance of Ring Sideroblast Quantification and Evaluation in Myelodysplastic Syndromes

Ring Sideroblast Quantification in Myelodysplastic Syndromes | myCME

AMA PRA Category 1 Credit(s)^TM

1.50 CME: Symposium on pathology of MDS-RS includes a cross-disciplinary interview enhanced by infographics and pathologist pocket guide. Exp 4/28/2023

$The ABCs of Targeting BCMA in Relapsed/Refractory Multiple Myeloma: How to Identify the Optimal Approach for Patients$

Targeting BCMA in Relapsed/Refractory Multiple Myeloma | myCME

AMA PRA Category 1 Credit(s)^TM, CE for Pharmacists, ANCC Contact Hour(s)

1.00 CME CE: Highlights benefits and risks of various BCMA-targeting strategies for patients with RRMM, including the side effects and toxicities. Exp 4/28/23

Combination and Sequencing Strategies With Proteasome Inhibitors in Multiple Myeloma: A GameOn! Challenge

Combination and Sequencing With PIs in Multiple Myeloma | myCME

AMA PRA Category 1 Credit(s)^TM

0.50 CME: Quiz yourself regarding the impact of patient characteristics, biomarkers, and treatment history on approved treatments for MM. Exp 11/29/22

Advances in Beta Thalassemia: Reducing Transfusion Burden With Novel Molecular Therapies

Beta Thalassemia Advances : Reducing Transfusion Burden | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists

1.00 CME CE: This interactive e-journal article covers pathophysiology, diagnostic criteria, clinical trial data, and transition preparedness strategies. Exp 3/11/2023

Navigating the Patient Journey in Chronic Lymphocytic Leukemia: Oncology Nurse Strategies in Therapy Management

CLL: Oncology Nurse Strategies in Therapy Management | myCME

ANCC Contact Hour(s)

1.00 CE: Emerging advances in CLL treatment with novel agents and the latest trial data for monotherapy and combination therapy strategies. Exp 12/2/22

Expert Perspectives on Rare Disease: Promoting Recognition, Diagnosis and Treatment of Cold Agglutinin Disease

Promoting Recognition, Diagnosis and Treatment of CAD

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s)

In this activity, Catherine M. Broome, MD, and Alexander Röth, MD, provide an understanding of the pathogenesis of Cold Agglutinin Disease (CAD) caused by cold-reacting IgM autoantibodies and reveal common clinical features.

$Setting the Stage for Success: Caring for Patients with Relapsed or Refractory Multiple Myeloma$

Caring for Patients with Relapsed or Refractory MM | myCME

ANCC Contact Hour(s), IPCE Credit(s)

1.00 CE: Cleveland Clinic’s Dr. Beth Faiman discusses MM treatment with the goal of keeping patients on therapy and maintaining their QOL. Exp 4/29/23

Practical Tools & Expert Guidance for the Nurse Navigator and Clinical Team: Strategies to Reduce Treatment Disparities in Multiple Myeloma

Reduce Treatment Disparities in Multiple Myeloma | myCME

AMA PRA Category 1 Credit(s)^TM, ANCC Contact Hour(s), CE for Pharmacists

1.00 CME/CE: Real-world strategies using data, guidelines, and decision-making recommendations to ensure the best care for patients with MM. Exp 12/23/22

Optimizing Care for Patients With FLT3-positive AML | myCME

AMA PRA Category 1 Credit(s)^TM

1.00 CME: Faculty discuss the importance of early diagnosis, current agents and treatment strategies, and pertinent patient-reported outcomes. Exp 12/31/22